Showing 108,161 - 108,176 results of 108,176 for search '(( i point decrease ) OR ( 5 ((((wt decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.92s Refine Results
  1. 108161

    Table_2_Cathepsins and Parkinson’s disease: insights from Mendelian randomization analyses.CSV by Aishanjiang Yusufujiang (12895259)

    Published 2024
    “…Cathepsin-cysteine proteases situated within lysosomes participate in a range of physiological and pathological processes, including the degradation of harmful proteins. Prior research has pointed towards a potential link between cathepsins and PD; however, the precise causal relationship between the cathepsin family and PD remains unclear.…”
  2. 108162

    Image_2_Cathepsins and Parkinson’s disease: insights from Mendelian randomization analyses.PDF by Aishanjiang Yusufujiang (12895259)

    Published 2024
    “…Cathepsin-cysteine proteases situated within lysosomes participate in a range of physiological and pathological processes, including the degradation of harmful proteins. Prior research has pointed towards a potential link between cathepsins and PD; however, the precise causal relationship between the cathepsin family and PD remains unclear.…”
  3. 108163

    Table_7_Cathepsins and Parkinson’s disease: insights from Mendelian randomization analyses.CSV by Aishanjiang Yusufujiang (12895259)

    Published 2024
    “…Cathepsin-cysteine proteases situated within lysosomes participate in a range of physiological and pathological processes, including the degradation of harmful proteins. Prior research has pointed towards a potential link between cathepsins and PD; however, the precise causal relationship between the cathepsin family and PD remains unclear.…”
  4. 108164

    Table_4_Cathepsins and Parkinson’s disease: insights from Mendelian randomization analyses.CSV by Aishanjiang Yusufujiang (12895259)

    Published 2024
    “…Cathepsin-cysteine proteases situated within lysosomes participate in a range of physiological and pathological processes, including the degradation of harmful proteins. Prior research has pointed towards a potential link between cathepsins and PD; however, the precise causal relationship between the cathepsin family and PD remains unclear.…”
  5. 108165

    Table_6_Cathepsins and Parkinson’s disease: insights from Mendelian randomization analyses.CSV by Aishanjiang Yusufujiang (12895259)

    Published 2024
    “…Cathepsin-cysteine proteases situated within lysosomes participate in a range of physiological and pathological processes, including the degradation of harmful proteins. Prior research has pointed towards a potential link between cathepsins and PD; however, the precise causal relationship between the cathepsin family and PD remains unclear.…”
  6. 108166

    Table_3_Cathepsins and Parkinson’s disease: insights from Mendelian randomization analyses.CSV by Aishanjiang Yusufujiang (12895259)

    Published 2024
    “…Cathepsin-cysteine proteases situated within lysosomes participate in a range of physiological and pathological processes, including the degradation of harmful proteins. Prior research has pointed towards a potential link between cathepsins and PD; however, the precise causal relationship between the cathepsin family and PD remains unclear.…”
  7. 108167

    Image_8_Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation.tif by Mario Pérez-Diego (14799367)

    Published 2023
    “…Mechanistically, WIN55,212-2 induced a metabolic and epigenetic shift in macrophages by decreasing LPS-induced mTORC1 signaling, commitment to glycolysis and active histone marks in pro-inflammatory cytokine promoters. …”
  8. 108168

    Image_4_Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation.tif by Mario Pérez-Diego (14799367)

    Published 2023
    “…Mechanistically, WIN55,212-2 induced a metabolic and epigenetic shift in macrophages by decreasing LPS-induced mTORC1 signaling, commitment to glycolysis and active histone marks in pro-inflammatory cytokine promoters. …”
  9. 108169

    Image_2_Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation.tif by Mario Pérez-Diego (14799367)

    Published 2023
    “…Mechanistically, WIN55,212-2 induced a metabolic and epigenetic shift in macrophages by decreasing LPS-induced mTORC1 signaling, commitment to glycolysis and active histone marks in pro-inflammatory cytokine promoters. …”
  10. 108170

    Image_7_Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation.tif by Mario Pérez-Diego (14799367)

    Published 2023
    “…Mechanistically, WIN55,212-2 induced a metabolic and epigenetic shift in macrophages by decreasing LPS-induced mTORC1 signaling, commitment to glycolysis and active histone marks in pro-inflammatory cytokine promoters. …”
  11. 108171

    Provider performance and facility readiness for managing infections in young infants in primary care facilities in rural Bangladesh by Jennifer A. Applegate (8707761)

    Published 2020
    “…Facility readiness was assessed using checklists completed by study staff at three time points. To assess provider performance, we extracted data for all infection cases from facility registers and compared providers’ diagnosis and treatment against the guidelines. …”
  12. 108172

    Image_6_Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation.tif by Mario Pérez-Diego (14799367)

    Published 2023
    “…Mechanistically, WIN55,212-2 induced a metabolic and epigenetic shift in macrophages by decreasing LPS-induced mTORC1 signaling, commitment to glycolysis and active histone marks in pro-inflammatory cytokine promoters. …”
  13. 108173

    Image_3_Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation.tif by Mario Pérez-Diego (14799367)

    Published 2023
    “…Mechanistically, WIN55,212-2 induced a metabolic and epigenetic shift in macrophages by decreasing LPS-induced mTORC1 signaling, commitment to glycolysis and active histone marks in pro-inflammatory cytokine promoters. …”
  14. 108174

    Data_Sheet_2_How to “Start Small and Just Keep Moving Forward”: Mixed Methods Results From a Stepped-Wedge Trial to Support Evidence-Based Processes in Local Health Departments.pdf... by Rebekah R. Jacob (8638377)

    Published 2022
    “…LHD staff completed a quantitative survey at 4 time points measuring their EBDM skills, organizational supports, and evidence-based interventions. …”
  15. 108175

    Deletion of the transmembrane helix promotes greater stability and biological activity. by Wei Yang (109917)

    Published 2024
    “…<b>(E)</b> Lysates prepared from cells expressing either NACC2-NTRK2 (left lanes) or NACC2-NTRK2-ΔTM (right lanes) and treated with cycloheximide for the indicated time points were examined by SDS-PAGE and immunoblotted for NTRK2 The left lanes show decreasing amounts of NACC2-NTRK2 in the presence of cycloheximide, while the right lanes reveal little or no change in NACC2-NTRK2-ΔTM under identical conditions. …”
  16. 108176

    Mode of virus transmission differentially steers susceptibility to entry inhibition. by Irene A. Abela (173068)

    Published 2012
    “…Red and black values denote IC50 (nM) of during cell-cell and cell-free transmission, respectively. Data points represent means of duplicates from three independent inhibition experiments. …”